Sarcopenic obesity in older adults: a clinical overview
This Review provides an overview of the pathogenesis, clinical outcomes and management of sarcopenic obesity.
This Review provides an overview of the pathogenesis, clinical outcomes and management of sarcopenic obesity.
This article reviews advances in incretin-based pharmacotherapy, including the latest glucagon-like peptide 1 (GLP1) receptor agonists (GLP1RAs), ‘GLP1 plus’ agents, which combine the benefits of these agonists with the activity of additional hormones, and oral GLP1RAs, which promise to extend the benefits of GLP1 therapy.